Likewise, mutations in C21ORF2 (also referred to as CFAP410 or LRRC76) have been identified in patients with SMD [42] and ALS [43]. The gene discussed is CFAP410; the disease is spondyloepimetaphyseal dysplasia, Strudwick type.